Monoclonal antibody for treatment of T-cell acute lymphoblastic leukemia (T-ALL)
A new immunotherapy strategy based on the administration of a monoclonal antibody specific for pre-TCR has been developed and validated in a preclinical human T-ALL xenotransplantation model in mice.